Bladder cancer comes in several forms, each with distinct characteristics and treatment challenges. Urothelial carcinoma (formerly called transitional cell carcinoma) accounts for about 90% of ...
The first barrier Grivas notes is limited infusion room capacity and the need for rapid chair turnover. Other external barriers for patients include transportation and lodging. Grivas highlights that ...
Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly ...
Clinical Trials Arena on MSN21h
Ractigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancerThe company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...
The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...
Small cell carcinoma of the urinary bladder (SCCB) is an extremely rare but aggressive tumour constituting less than 0.7% of all urinary bladder tumours. It is often misdiagnosed as transitional cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback